Rewriting the Commercial Playbook for the Agentic Era

EXECUTIVE SUMMARY

Key Takeaways from Axtria Ignite

• The path forward is agentic — but earned, not leapt. Commercial operations are evolving from a fixed, calendar-based model toward trusted, agentic AI one step at a time, with data foundations first.
• Trust and adoption — not technology — decide who scales. Value emerges function by function across commercial operations — fastest where cycles are quick and reversible, most cautiously where money and compliance are at stake. The winners set explicit human-in-the-loop boundaries and fund change management as the majority of the work.
• Agentic AI earns its keep across the value chain. Value emerges function by function across commercial operations — fastest where cycles are quick and reversible, most cautiously where money and compliance are at stake.

The advantage no longer goes to the company that deploys the most AI — it goes to the one that sequences it most deliberately. Across pharma commercial operations, the debate has already shifted from whether to pilot AI to what is ready to scale, and most leaders already have what they need: deep data, hard-won expertise and a mandate to move faster. What will define the next era is not isolated use cases but disciplined, governed execution across the commercial organization.

Here are three takeaways for commercial and sales-operations leaders:

1. Agentic maturity is built, not bought

For a decade, commercial operations optimized for predictability — annual cycles, layered reporting, in-person reach. That model still works, which is precisely the problem. Three forces now expose its limits: tempo (compressed launch timelines), access (leaner field forces and tighter physician access, according to industry reports), and noise (myriad dashboards reps cannot navigate). The instinct is to bolt AI onto the existing model; the leaders pulling ahead are instead rebuilding the model itself. The response is not a leap to autonomous commercial operations but a deliberate evolution — foundations first, then trusted agents, then the people to adopt them, and only then autonomy.

“There is a disconnect between what the rep wants versus the home office. We have so much data … less is more. The reps want less, but more accurate. We are all competing for the reps’ attention.” - Francisco Vizuet, Director of Commercial Operations, Ferring

The journey begins with the basics — clean data, shared definitions, a single source of truth — and builds toward more autonomous capabilities over time. Most organizations are still on that first step, and the value comes from climbing deliberately rather than skipping ahead. The leaders proving it out start with the plumbing: AstraZeneca rebuilt its operating rhythm around agility and accountability, cutting its dynamic-targeting data lag from four-to-six months to one.

“We’ve improved cycle times over the last three years by 59%. Some of these things are small — the meme of ‘should it have been an email?’ Did we really need a meeting for that? People still want the email, but we can’t keep doing all these meetings. It’s really pushing people, and holding them to the timelines we’ve set.” - Jeanne Guest, Senior Director, Strategic Field Operations, AstraZeneca

Operational speed is only part of the story. The harder part of the foundation is rarely technical; it is definitional — across a multi-market organization, a word like “segmentation” can mean different things to marketing, sales and analytics, and the divergence surfaces exactly at the point of scale. Aligning on shared definitions, market archetypes and a single source of truth is unglamorous work, but it is what separates AI that scales from pilots that stall. It is also why the temptation to jump straight to the frontier is so risky.

“Organizations want to leapfrog to another industry’s level, but they don’t put enough effort into making their hands dirty — into building the foundations first.” - Hans Muehlberger, Executive Director, MSD Europe

2. The bottleneck isn’t technology — it’s trust and adoption

As agentic AI moves from demo to deployment, the question shifts from “can the system do it?” to “how much can we hand over?” Disciplined leaders judge it against three tests — reversibility, determinism and context. When all three are met, it is safe to let the system run; when any one falls short, a human stays in the loop. Incentive modeling is the archetype: agents generate scenarios and trade-offs, and a human makes the call.

“For trust I use three categories: reversibility, determinism and context. If it’s IC — money — you have to be deterministic. The system can run five scenarios and lay out the trade-offs, but the human makes the decision.” - Hardik Ghatalia, Director of Incentive Compensation, Regeneron

The tension underneath is real: the enterprise expects exact, repeatable answers while models are probabilistic by design. Reconciling the two is less about waiting for better models than about matching the tool to the tolerance — utmost precision where money moves, more latitude where the cost of being approximately right is low — and holding trust in place with transparent, auditable trails.

“Around 60 to 70% of the effort needs to go into change management. If we translate what we want to do into real benefits for our people — and tell the story that way — that’s the best change management we can have, because then people want to embrace it.” - Hans Muehlberger, Executive Director, MSD Europe

But earning buy-in at launch is not the finish line. Because the technology keeps moving, the support and the story have to be sustained well beyond go-live — a standing capability, not a one-time campaign.

“The change management strategy needs to stay forever. The technology changes so fast that we need dedicated teams to maintain engagement — without that, adoption drops.” - Francisco Vizuet, Director of Commercial Operations, Ferring

3. Autonomy is earned, function by function

Autonomy arrives function by function, each at its own trust threshold. Industry research points to double-digit revenue gains and meaningful cost savings from agentic, personalized approaches, with substantial value on the table for large pharma companies over time. The point is not to automate everything at once, but to place agents where they create value and can be trusted. Across the value chain, the opportunity is concrete and here is how the Axtria SalesIQ^TM Agentic Ecosystem empowers it:

• Segmentation and targeting: Dynamic, agent-refreshed segments that compress cycles from months to weeks. The Segmentation & Targeting Agentic Ecosystem cuts the S&T cycle by roughly 60% (about eight weeks to three) and effort and cost by half, while lifting scenario agility and keeping every segment governed and audit ready.
• Territory alignment : Agents propose and rebalance alignments; humans approve the trade-offs. The Alignment Design Agent and Alignment Field Co-Pilot automate territory design and HO–field collaboration — scoring every proposed change across workload, disruption and revenue-at-risk before it is committed and cutting planning cycles by roughly 40%.
• Incentive compensation : The highest bar: agents model scenarios, humans own the decision, because it is people’s pay. The IC Plan Design, Health-Check & Benchmarking and Payout Validation agents model, deploy and continuously health-check incentive plans — validating every payout to 99.9%+ accuracy with near-zero clawback and cutting IC inquiries by ~70%, so reps trust that every payout is right.
• Call plans: The move from calendar-based cycles toward weekly or even daily plans. The Targeting Agent turns segments into tiered, territory-specific call plans that self-refine on execution feedback, flagging over- and under-coverage automatically.
• Field experience: One conversational surface that collapses today’s tool sprawl into a single trusted assistant. The unified field experience offers a full agentic rep copilot that auto-selects the right agent from a natural-language query, spanning pre-call planning, post-call capture, visit planning and instant performance answers.

Full autonomy will arrive only where it is earned — accurate quarter after quarter, transparent and auditable — and that bar rises steeply wherever money is at stake. Industry research is a caution flag: nearly every organization has experimented with AI, but only a small share have turned it into consistent financial value. The distance between experimentation and impact is not a technology gap; it is the real contest.

“It’s here. We’re going to have to do it — embrace it and figure out how to make it work properly. The biggest challenge is us: we have to keep upskilling ourselves.” - Jeanne Guest, Senior Director, Strategic Field Operations, AstraZeneca

That urgency collides with how the work is still organized. Much of commercial operations runs on fixed, periodic cycles even as the market moves continuously — and closing the gap between that cadence and reality is the real test of readiness.

“We’re still on a stagnant, calendar-based model — IC and goals set quarterly or yearly — while market dynamics change much faster. Until the processes adapt to that speed, we’re only pretending we can compete.” - Hardik Ghatalia, Director of Incentive Compensation, Regeneron

The organizations that lead the next two years will not be those that deploy the most AI, but those that sequence it best — turning today’s pilots into durable advantage by refusing to skip the steps that make autonomy safe. The commercial playbook is being rewritten now, and the advantage will go to those who write it deliberately.

The mandate for commercial leaders

• Fix the foundations first. Shared definitions, low data latency and one source of truth beat another dashboard — foundations are the precondition for AI, not a parallel project.
• Set the trust boundary explicitly. Use reversibility, determinism and context to decide what automates and what keeps a human in the loop — tightest where money moves.
• Fund change management as the majority of the work. Staff it as a permanent capability and frame every rollout in the language of rep benefit.
• Sequence agentic AI across the value chain. Start where cycles are slow and reversible; reserve incentive compensation and other money-critical decisions until agents have earned trust.

Note: Quotations are drawn from a panel of commercial and sales-operations leaders and attributed by name.